Endometriosis Toolkit: Endo45 vs Endometriosis Diary for "endometriosis app"
Endometriosis Toolkit: Endo45
Chronic Pain and Symptom Tracking & Treatment at Your Finger Tips
Endometriosis Diary
Track your period and symptoms. Get full insights and share your data securely.
Rank
4
For keyword
Rank
1
English (United States)Chronic Pain and Symptom Tracking & Treatment at Your Finger Tips
Track your period and symptoms. Get full insights and share your data securely.
Endometriosis Toolkit: Endo45 owns the first impression with transformation headlines like "From Helpless to In Control" and screenshot 1's two women using the app together, while Endometriosis Diary stays on plain UI frames. Endometriosis Diary, however, makes what the app does far clearer with a 6-month pain chart, a colour-coded severity calendar and a share-with-clinician screen. It also carries a clinical framing that Endometriosis Toolkit: Endo45 never surfaces visually.
Scanned screenshots4 a · 4 b
Only the first 4 screenshots from each side are sent to the AI. These are what users see in App Store and Google Play search results, so they carry most of the conversion weight.
App A
App B
Value Proposition
A leadsEvery caption sells a change of state: "From Frustration to Freedom", "Go beyond what doctors offer", plus a personalised EndoFit plan and score.
Endometriosis Diary's opening caption promises "a complete overview of your endometriosis", a clear functional benefit, but no outcome or change is named.
Clarity
B leadsEndometriosis Toolkit's phone frames all show onboarding slides; only screenshot 3's "Juliet's Plan" card list hints at day-to-day functionality.
Endometriosis Diary shows a 6-month pain chart, a severity calendar with day counts, and toggles for bowel, mood and sleep questions.
Emotional Hook
A leadsScreenshot 1 pairs two women sharing a phone with "Say goodbye to years of frustration, confusion, and worry"; screenshot 4 says "Juliet you're struggling".
Endometriosis Diary's captions name capabilities, "View the calendar to see your entries at a glance", over UI frames with no user pictured.
Trust Signals
B leadsNo badges, testimonials or specialist credits appear in any Endometriosis Toolkit screenshot; the "evidence-backed" claim sits in small onboarding body text.
Endometriosis Diary surfaces a "MEDGuideline" mark and white-coat clinician illustrations giving daily tips and receiving shared data: self-claimed clinical framing, not attested.
Reviews of Endometriosis Toolkit: Endo45 cluster around one dominant complaint: the app asks for an account and a payment plan before any content can be seen, with several reviewers also naming the $14.99 monthly price and sign-in failures. The same review set praises the depth of the endometriosis information, the nutrition advice, and the ability to track symptoms and progress over time. Endometriosis Diary has only two reviews on file, one negative about a trial charge and one positive, which is too little evidence to establish any recurring theme.
App A
Pain points
Paywall before any content is visible
HighSubscription price seen as too high
MediumSign-in and account access failures
MediumStrengths
Depth of endometriosis information
HighNutrition advice with felt symptom relief
MediumTracking and progress visualisation
MediumApp B
Pain points
No recurring complaints found.
Strengths
No recurring praise found.
Endometriosis Toolkit: Endo45 positions itself as a paid transformation programme, promising a personalised action plan and a roadmap toward "endo remission, not just temporary relief". Endometriosis Diary positions itself as a clinically-grounded symptom log, built "in collaboration with gynecologists and endometriosis specialists" and framed around sharing data securely. The mismatch is outcome-ambition versus medical credibility: one sells change, the other sells evidence a doctor will accept.
App A
Positioning
Holistic endo remission programme
Target audience
Women with endometriosis and ongoing chronic pelvic pain
Value promise
A personalised plan that pursues remission, not just symptom relief
Tone
empathetic, motivational, offer-driven
App B
Positioning
Clinician-backed symptom diary
Target audience
People tracking endometriosis symptoms alongside medical care
Value promise
See symptom patterns over time and share them securely with clinicians
Tone
calm, factual, clinically framed
Gap
Endometriosis Toolkit: Endo45 leads with a personalised programme aimed at "endo remission" and daily habit change, while Endometriosis Diary leads with clinical provenance and doctor-shareable data, so one competes on ambition and the other on medical trust.
Opportunity
Endometriosis Toolkit: Endo45 can own the searcher who has already logged symptoms for months and wants a next step, since Endometriosis Diary promises visibility into the condition but never claims to change it.
Risk
The subscription block, "$79.99/year (was $179.99) - save 55%", sits in the opening screen of the description ahead of any clinical grounding, and the title says "Endo45" while the body brands itself EndoFit. For a chronic-condition audience weighing a listing that names gynecologist involvement, price-first framing plus two product names invites hesitation at exactly the moment trust is being formed.
Strategic advantage
The remission framing is a claim no symptom log makes, and it speaks directly to long-diagnosed users who are past tracking and frustrated that logging has not reduced pain. That buying motive supports a subscription price in a way a diary cannot.
Missed opportunity
Neither listing speaks to the pre-diagnosis stage, the years of suspected endometriosis before a laparoscopy confirms it. Both assume a confirmed diagnosis, leaving the searcher who is still trying to be believed by a clinician unaddressed.
App A
57
Endometriosis Toolkit: Endo45
Slight lead
A wins
App B
43
Endometriosis Diary
Slight gap
Endometriosis Diary holds rank 1 for endometriosis app while Endometriosis Toolkit: Endo45 sits at 4, but the underlying listing strength runs the other way: Endo45 leads on keyword fit, positioning and conversion. That gap makes Endometriosis Diary's top position look held by its clean, literal title rather than by the depth of its listing.
Why it wins
Endometriosis Toolkit: Endo45 pairs the strongest keyword optimisation on the page with transformation-led creative like "From Helpless to In Control" and a remission promise no symptom log makes, while Endometriosis Diary rests on clinical provenance and plain UI frames. The result is a listing that converts searcher intent into a reason to install, not just a description of logging.
Biggest opportunity
The title already carries endometriosis app intent through Endometriosis Toolkit, so the gain now sits in conversion: making the remission outcome legible in the short description instead of the generic tracking line it currently runs.
Next priority
Test a short description that leads with the differentiated outcome, such as "Endometriosis app for a personalised plan aimed at remission, not just logs" (74 characters). The parallel test is moving the $79.99/year block below that promise, since reviews repeatedly cite paying before seeing content.
Run your own comparison
Compare more apps, in any market or language.
See AI recommendations on how to beat your competitor.
Track keyword rankings across every store and locale. Free to start.
Try AppTracker free